Science in Action: How Clinical Trials are Changing Kidney Cancer Treatment

Tuesday, May 19th at 6:00pm EST

Learn Directly from Physicians Who Are Leading Kidney Cancer Clinical Trials

Clinical trials are where the future of kidney cancer treatment begins and the physicians speaking at this program are not just observers. They are actively involved in designing, leading, and delivering the clinical trials that are shaping patient care today. This panel brings together genitourinary oncology specialists from Moffitt Cancer Center and the University of Florida, major academic cancer centers at the forefront of kidney cancer research.

These physicians care for kidney cancer patients every day and work directly on clinical trials evaluating new immunotherapies, targeted therapies, and emerging treatment strategies.

They are helping answer the questions that matter most:

  • Which new therapies show the greatest promise

  • How treatments are improving survival and quality of life

  • Which patients may benefit from clinical trial participation

  • What advances are coming next and how soon

For patients and caregivers, this is a rare opportunity to hear directly from physicians who are not only treating kidney cancer, but actively advancing the science behind it. Whether you are newly diagnosed, in treatment, or navigating long-term care, this conversation offers information to help you better understand your options and the direction kidney cancer treatment is heading.

The session concludes with a live Q&A, giving you the opportunity to ask questions directly to the physicians leading this work.

Registration for this virtual event is free, but we may send you
updates about future events via email.

After registering a link will be emailed to you with details
on how to join via Zoom.